Epstein-Barr virus DNA detection by targeted sequencing in post-treatment plasma samples and prognosis of locally advanced nasopharyngeal cancer: implications for clinical research
- PMID: 35598800
- DOI: 10.1016/j.annonc.2022.05.005
Epstein-Barr virus DNA detection by targeted sequencing in post-treatment plasma samples and prognosis of locally advanced nasopharyngeal cancer: implications for clinical research
Conflict of interest statement
Disclosure The authors have declared no conflicts of interest.
Comment on
-
Improved risk stratification of nasopharyngeal cancer by targeted sequencing of Epstein-Barr virus DNA in post-treatment plasma.Ann Oncol. 2022 Aug;33(8):794-803. doi: 10.1016/j.annonc.2022.04.068. Epub 2022 Apr 29. Ann Oncol. 2022. PMID: 35491007
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
